市北高新：10月24日召开董事会会议

Group 1 - The company Shibei Gaoxin (SH 600604) held its 24th meeting of the 10th board of directors on October 24, 2025, via telecommunication to discuss the proposal for the second extraordinary general meeting of shareholders in 2025 [1] - For the first half of 2025, Shibei Gaoxin's revenue composition was as follows: leasing and business services accounted for 65.85%, real estate accounted for 34.13%, and other businesses accounted for 0.03% [1] - As of the report date, Shibei Gaoxin's market capitalization was 12.2 billion yuan [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, indicating a hot secondary market in biomedicine, while the primary market is facing challenges in fundraising [1]